An Examination of Colonoscopy Outcomes in a Tertiary Care Hospital
Abstract
Introduction: Colonoscopy is a safe, validated method for visualising the entire lower gastrointestinal tract from the rectum to the terminal ileum, and additionally enables endoscopic biopsy and polypectomy, expanding both diagnostic and therapeutic options for clinicians. Methods: Data were obtained from the endoscopy database of patients undergoing colonoscopy at the study institution between March 2023 and March 2024. This retrospective study used data extracted directly from the endoscopy database to maximise validity and reliability. Results: A total of 100 patients underwent colonoscopy during the one-year study period. Sedation was administered in 70% of patients, while the remaining 30% completed the procedure using local anaesthesia alone. The caecum was reached in 70% of procedures. The primary indication for colonoscopy was per-rectal bleeding (24%). The most common pathological findings were localised to the rectum and anal canal (34%). Four of 100 patients were diagnosed with carcinoma — two adenocarcinomas arising from the rectosigmoid, one melanoma of the anal canal, and one squamous cell carcinoma. Twenty patients underwent polypectomy, with only one case of post-polypectomy rebleeding. In conclusion, colonoscopy is an effective and safe diagnostic method for lower gastrointestinal symptoms and should remain a standard component of patient management.